​

CVS Health (CVS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CVS Stock Forecast

CVS Health (CVS) stock forecast, based on 41 Wall Street analysts, predicts a 12-month average price target of $95.15, with a high of $103.00 and a low of $90.00. This represents a 25.08% increase from the last price of $76.07.

$40 $53 $66 $79 $92 $105 High: $103 Avg: $95.15 Low: $90 Last Closed Price: $76.07

CVS Stock Rating

CVS Health stock's rating consensus is Buy, based on 41 Wall Street analysts. The breakdown includes 2 Strong Buy (4.88%), 32 Buy (78.05%), 7 Hold (17.07%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 41 0 7 32 2 Strong Sell Sell Hold Buy Strong Buy

CVS Price Target Upside V Benchmarks

TypeNameUpside
StockCVS Health25.08%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Plans Stocks30.38%

Price Target Trends

1M3M12M
# Anlaysts1323
Avg Price Target$98.00$93.00$91.39
Last Closing Price$76.07$76.07$76.07
Upside/Downside28.83%22.26%20.14%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 266175--28
Feb, 266174--27
Jan, 266174--27
Dec, 256175--28
Nov, 256165--27
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 05, 2026Michael ChernyLeerink Partners$98.00$79.4923.29%28.83%
Jan 28, 2026Argus Research$90.00$73.2122.93%18.31%
Jan 06, 2026Bernstein$91.00$80.5712.95%19.63%
Dec 12, 2025Bernstein$87.00$80.847.62%14.37%
Dec 10, 2025Ann HynesMizuho Securities$95.00$79.0520.18%24.88%
Dec 10, 2025Robert W. Baird$92.00$78.2417.59%20.94%
Dec 10, 2025Jessica TassanPiper Sandler$101.00$78.2429.09%32.77%
Dec 10, 2025Morgan Stanley$93.00$78.2418.87%22.26%
Dec 10, 2025Barclays$93.00$78.2418.87%22.26%
Dec 10, 2025Kevin CaliendoUBS$97.00$78.2423.98%27.51%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 13, 2026Cowen & Co.BuyBuyhold
Mar 05, 2026Leerink PartnersOutperformOutperformhold
Jan 06, 2026BernsteinMarket PerformMarket Performhold
Dec 10, 2025Cantor FitzgeraldOverweightOverweighthold
Dec 10, 2025Piper SandlerOverweightOverweighthold
Dec 10, 2025Morgan StanleyOverweightOverweighthold
Dec 10, 2025BarclaysOverweightOverweighthold
Dec 10, 2025UBSOutperformOutperformhold
Dec 10, 2025Bank of America SecuritiesBuyBuyhold
Dec 04, 2025BernsteinMarket PerformMarket Performhold

Financial Forecast

EPS Forecast

$1 $3 $5 $7 $9 $11 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$6.00$3.29$6.49$3.66$1.40---
Avg Forecast$8.25$8.63$8.61$5.15$5.87$6.88$8.19$10.15
High Forecast$8.43$8.95$8.64$5.81$7.03$8.43$8.98$10.69
Low Forecast$8.09$8.32$8.59$4.65$5.34$5.83$7.49$9.66
Surprise %-27.27%-61.88%-24.62%-28.93%-76.15%---

Revenue Forecast

$250B $300B $350B $400B $450B $500B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$292.11B$322.47B$357.78B$372.81B$402.07B---
Avg Forecast$290.59B$315.12B$354.36B$371.88B$385.40B$405.34B$421.93B$443.77B
High Forecast$295.45B$324.21B$356.91B$373.69B$401.00B$405.76B$424.16B$461.94B
Low Forecast$286.05B$306.42B$351.62B$367.69B$372.45B$404.92B$419.69B$427.19B
Surprise %0.52%2.33%0.96%0.25%4.32%---

Net Income Forecast

$0 $3B $6B $9B $12B $15B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$8.00B$4.31B$8.34B$4.61B$1.77B---
Avg Forecast$6.83B$7.85B$8.34B$6.75B$7.97B$9.20B$10.62B$13.09B
High Forecast$8.19B$9.42B$10.01B$7.50B$9.06B$10.88B$11.58B$13.79B
Low Forecast$5.46B$6.28B$6.68B$6.00B$6.88B$7.52B$9.66B$12.46B
Surprise %17.17%-45.10%--31.65%-77.83%---

CVS Forecast FAQ

Is CVS Health stock a buy?

CVS Health stock has a consensus rating of Buy, based on 41 Wall Street analysts. The rating breakdown includes 2 Strong Buy, 32 Buy, 7 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that CVS Health is a favorable investment for most analysts.

What is CVS Health's price target?

CVS Health's price target, set by 41 Wall Street analysts, averages $95.15 over the next 12 months. The price target range spans from $90 at the low end to $103 at the high end, suggesting a potential 25.08% change from the previous closing price of $76.07.

How does CVS Health stock forecast compare to its benchmarks?

CVS Health's stock forecast shows a 25.08% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the healthcare plans stocks industry (30.38%).

What is the breakdown of analyst ratings for CVS Health over the past three months?

  • March 2026: 21.43% Strong Buy, 60.71% Buy, 17.86% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 22.22% Strong Buy, 62.96% Buy, 14.81% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 22.22% Strong Buy, 62.96% Buy, 14.81% Hold, 0% Sell, 0% Strong Sell.

What is CVS Health’s EPS forecast?

CVS Health's average annual EPS forecast for its fiscal year ending in December 2026 is $6.88, marking a 391.43% increase from the reported $1.4 in 2025. Estimates for the following years are $8.19 in 2027, and $10.15 in 2028.

What is CVS Health’s revenue forecast?

CVS Health's average annual revenue forecast for its fiscal year ending in December 2026 is $405.34B, reflecting a 0.81% increase from the reported $402.07B in 2025. The forecast for 2027 is $421.93B, and $443.77B for 2028.

What is CVS Health’s net income forecast?

CVS Health's net income forecast for the fiscal year ending in December 2026 stands at $9.2B, representing an 420.34% increase from the reported $1.77B in 2025. Projections indicate $10.62B in 2027, and $13.09B in 2028.